Disclosures for "Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital"
-
Dr. Nasir has nothing to disclose.
-
Dr. No has nothing to disclose.
-
Miss Rabvukwa has nothing to disclose.
-
Mrs. Fuller has nothing to disclose.
-
Dr. Azzopardi has nothing to disclose.
-
Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Chaudhuri has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ.
-
Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK SERONO.